Sonnet BioTherapeutics Holdings, Inc. Profile Avatar - Palmy Investing

Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human sin…

Biotechnology
US, Princeton [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Sonnet BioTherapeutics Holdings, Inc. has no acquisition track records yet.

M&A Deals · History

Sonnet BioTherapeutics Holdings, Inc. has no acquisition track records yet.

End of SONN's Analysis
CIK: 1106838 CUSIP: 83548R105 ISIN: US83548R3030 LEI: - UEI: -
Secondary Listings
SONN has no secondary listings inside our databases.